On Tuesday, IDEXX Laboratories Inc. (NASDAQ:IDXX) shares closed at $457.38, marking a 1.58% increase, breaking the company's two-day losing streak. This rise came in contrast to...
In a recent lawsuit, Johnson & Johnson (NYSE: JNJ) and Procter & Gamble Co (NYSE: PG) are facing allegations of misleading consumers regarding decongestant cold medicines...
On Sunday night, AstraZeneca Plc (NASDAQ: AZN) presented the Phase 3 FLAURA2 results evaluating Tagrisso plus chemotherapy versus Tagrisso monotherapy as first-line treatment for...
HSBC initiated coverage of 11 U.S. biopharmaceutical and healthcare stocks in a note to clients on Wednesday. Analysts assigned Actinium Pharmaceuticals Inc (NYSE:ATNM), Amgen...
Janssen, a unit of Johnson & Johnson (NYSE: JNJ), released topline results from the three-arm Phase 3 MARIPOSA-2 study evaluating Rybrevant (amivantamab-vmjw) regime versus...
Johnson & Johnson (NYSE: JNJ) is gearing up to use the proceeds from the recent separation of its consumer-health segment Kenvue Inc (NYSE: KVUE) to bolster its growth...
(Reuters) - Nvidia Corp’s market capitalization climbed higher in August thanks to its strong profit forecasts, which defied the broader downtrend in mega-cap technology stocks...
Berkshire Hathaway (NYSE:BRKa), led by CEO Warren Buffett, continues to see significant gains from its investment strategy focusing on profitable, brand-name businesses. The...